emcardioНеотложная кардиология и кардиоваскулярные рискиEmergency Cardiology and Cardiovascular Risks journal2616-633XБелорусский государственный медицинский университетemcardio-275Research ArticleОригинальные научные публикацииOriginal Scientific ResearchВозможности антиангинальной терапии у пациентов с неполной реваскуляризацией миокарда в отдаленном периоде первичного чрескожного коронарного вмешательстваAntianginal treatment options of patients with incomplete myocardial revascularization in the long-term period after primary percutaneous coronary interventionЦапаеваН. Л.TsapaevaN. L.ТарашкевичН. В.TarashkevichN. V.МироноваЕ. В.MironovaE. V.ЧерноглазП. Ф.ChernoglazP. F.ЮрлевичД. И.YurievichD. I.Белорусский государственный медицинский университетBelarusУчреждение здравоохранения «1 городская клиническая больница»BelarusУчреждение здравоохранения «9 городская клиническая больница»Belarus20181311202522392396Copyright © Цапаева Н.Л., Тарашкевич Н.В., Миронова Е.В., Черноглаз П.Ф., Юрлевич Д.И., 20252025Цапаева Н.Л., Тарашкевич Н.В., Миронова Е.В., Черноглаз П.Ф., Юрлевич Д.И.Tsapaeva N.L., Tarashkevich N.V., Mironova E.V., Chernoglaz P.F., Yurievich D.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://emcardio.bsmu.by/jour/article/view/275

Цель Исследовать клинический статус и состояние микроциркуляции у пациентов ИБС с неполной реваскуляризацией миокарда в отдаленном периоде первичного ЧКВ и изучить возможность использования препарата ранолазин у этой категории пациентов.

The aim of the present study is to investigate the clinical and microcirculatory status and possibilities of ranolazin treatment in patients with in complete myocardial revascularization in long -term follow -up after primary percutaneous coronary intervention.

чрезкожное коронарное вмешательствополная и неполная реваскуляризация миокардамикроциркуляцияранолазинpercutaneous coronary interventioncomplete and incomplete myocardial revascularizationmicrovascular dysfunctionranolazinReferencesWijns W., Kolh P., Danchin N., Di Mario C., Falk V., Folliguet T., Garg S., Huber K., James S., Knuuti J., Lopez-Sendon J., Marco J., Menicanti L., Ostojic M., Piepoli M.F., Pirlet C., Pomar J.L., Reifart N., Ribichini F.L., Schalij M.J., Sergeant P., Serruys P.W., Silber S., Sousa Uva M., Taggart D. [Collaborators 58] Guidelines on myocardial revascularization. Eur Heart J, 2010, vol. 31, № 20, pp. 2501-555. doi: 10.1093/eurheartj/ehq277.Wijns W., Kolh P., Danchin N., Di Mario C., Falk V., Folliguet T., Garg S., Huber K., James S., Knuuti J., Lopez-Sendon J., Marco J., Menicanti L., Ostojic M., Piepoli M.F., Pirlet C., Pomar J.L., Reifart N., Ribichini F.L., Schalij M.J., Sergeant P., Serruys P.W., Silber S., Sousa Uva M., Taggart D. [Collaborators 58] Guidelines on myocardial revascularization. Eur Heart J, 2010, vol. 31, № 20, pp. 2501-555. doi: 10.1093/eurheartj/ehq277.Widimsky P., Fajadet J Danchin N., Wijns W. «Stent 4 Life». Targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac. Eurolntervention, 2009, vol. 4, № 5, pp. 555-557.Widimsky P., Fajadet J Danchin N., Wijns W. «Stent 4 Life». Targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac. Eurolntervention, 2009, vol. 4, № 5, pp. 555-557.Safley D.M., House J.A., Marso S.P., Grantham J.A., Rutherford B.D. Im provem ent in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel. JACC Cardiovasc Interv, 2008, vol. 1, № 3, pp. 295-302Safley D.M., House J.A., Marso S.P., Grantham J.A., Rutherford B.D. Im provem ent in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel. JACC Cardiovasc Interv, 2008, vol. 1, № 3, pp. 295-302Meier B., Luethy P., Finci L., Steffenino G.D., Rutishauser W. Coronary wedge pressure in relation to spontaneously visible and recruitable collaterals. Circulation, 2008, vol.75, № 5, pp. 906-913.Meier B., Luethy P., Finci L., Steffenino G.D., Rutishauser W. Coronary wedge pressure in relation to spontaneously visible and recruitable collaterals. Circulation, 2008, vol.75, № 5, pp. 906-913.Sambuceti G., Marzilli M., Mari A., Marini C., Schluter M., Testa R., Papini M., Marraccini P., Ciriello G., Marzullo P., L’Abbate A. Coronary m icrocirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium. Am J Physiol Heart Circ Physiol, 2005, vol. 288, № 5, pp. H2298-H2305.Sambuceti G., Marzilli M., Mari A., Marini C., Schluter M., Testa R., Papini M., Marraccini P., Ciriello G., Marzullo P., L’Abbate A. Coronary m icrocirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium. Am J Physiol Heart Circ Physiol, 2005, vol. 288, № 5, pp. H2298-H2305.Safley D., House J. Marso S. (2008) / Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel. JACC Cardiovasc Interv., vol. 1(3), pp. 295-302.Safley D., House J. Marso S. (2008) / Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel. JACC Cardiovasc Interv., vol. 1(3), pp. 295-302.Tsapaeva N.L., Chernoglaz P.F., Yurlevich D.I., Mironova E.V., Kolb M.V., Zhuk O.I. Otdalennye rezul’taty endovaskulyarnoy revaskulyarizazii miokarda u pazientov s ostrym koronarnym sindromom [Long-term effectiveness of endovascular myocardil revascularization in patients with acute coronary syndrome]. Kardiologiya vBelarusi, vol. 9, № 3, pp. 614­619. (in Russian).Tsapaeva N.L., Chernoglaz P.F., Yurlevich D.I., Mironova E.V., Kolb M.V., Zhuk O.I. Otdalennye rezul’taty endovaskulyarnoy revaskulyarizazii miokarda u pazientov s ostrym koronarnym sindromom [Long-term effectiveness of endovascular myocardil revascularization in patients with acute coronary syndrome]. Kardiologiya vBelarusi, vol. 9, № 3, pp. 614­619. (in Russian).Tsapaeva N.L., Tarashkevich N.V., Mironova E.V., Jn Shojan, Konstantinova E.E., Chernoglaz P.F., Yurlevich D.I. M ikrozirkulyatornaya disfunkziya u pazientov s nepolnoy revaskulyarizaziey miokarda v otdalennom periode pervichnogo chrezkozhnogo koronarnogo vmeshatel’stva (vozmozhnosti diagnostiki i lecheniya) [M icrovascular dysfunction in patients with incomplete myocardial revascularization in the long-term period of primary percutaneous coronary intervention (diagnosis and treatment opportunities)]. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski, 2017, vol. 1, № 1, pp. 125-130. (in Russian).Tsapaeva N.L., Tarashkevich N.V., Mironova E.V., Jn Shojan, Konstantinova E.E., Chernoglaz P.F., Yurlevich D.I. M ikrozirkulyatornaya disfunkziya u pazientov s nepolnoy revaskulyarizaziey miokarda v otdalennom periode pervichnogo chrezkozhnogo koronarnogo vmeshatel’stva (vozmozhnosti diagnostiki i lecheniya) [M icrovascular dysfunction in patients with incomplete myocardial revascularization in the long-term period of primary percutaneous coronary intervention (diagnosis and treatment opportunities)]. Neotlozhnaya kardiologiya i kardiovaskulyarnye riski, 2017, vol. 1, № 1, pp. 125-130. (in Russian).Prasad A., Rihal C.S., Lennon R.J., Wiste H.J., Singh M., Holmes D.R.Jr. Trends in outcomes after percutaneous coronary intervention for chronic totalocclusions: a 25-year experience from the mayo clinic. J A m Coll Cardiol, 2007, vol. 49, № 15, pp. 1611-1618.Prasad A., Rihal C.S., Lennon R.J., Wiste H.J., Singh M., Holmes D.R.Jr. Trends in outcomes after percutaneous coronary intervention for chronic totalocclusions: a 25-year experience from the mayo clinic. J A m Coll Cardiol, 2007, vol. 49, № 15, pp. 1611-1618.Aslam S., Gray D. Ranolazine (Ranexa) in the treatment of chronic stable angina. Adv Ther, 2010, vol. 27, № 4, рр. 193-201.Aslam S., Gray D. Ranolazine (Ranexa) in the treatment of chronic stable angina. Adv Ther, 2010, vol. 27, № 4, рр. 193-201.Letienne R., Vie B., Puech A., Vieu S., Le Grand B., John G.W. Evidence that ranolazine behaves as a weak beta1- and beta2- adrenoceptor antagonist in the cat cardiovascular system. N aunyn Schmiedebergs Arch Pharmacol, 2001, vol. 363, № 4, рр. 464-471.Letienne R., Vie B., Puech A., Vieu S., Le Grand B., John G.W. Evidence that ranolazine behaves as a weak beta1- and beta2- adrenoceptor antagonist in the cat cardiovascular system. N aunyn Schmiedebergs Arch Pharmacol, 2001, vol. 363, № 4, рр. 464-471.Estacion M., Waxman S.G., Dib-Hajj S.D. Effects of ranolazine on wildtype and mutant hNav1.7 channels and on DRG neuron excitability. M ol Pain, 2010, vol. 6, № 35, рр. 35. doi: 10.1186/1744-8069-6-35.Estacion M., Waxman S.G., Dib-Hajj S.D. Effects of ranolazine on wildtype and mutant hNav1.7 channels and on DRG neuron excitability. M ol Pain, 2010, vol. 6, № 35, рр. 35. doi: 10.1186/1744-8069-6-35.Karpov Yu.A. Antianginal’naya terapiya: fokus na ranolazin [Antianginal Therapy: Focus on Ranolazine]. Consilium medicum, 2013, № 5, pp. 26­30. (in Russian).Karpov Yu.A. Antianginal’naya terapiya: fokus na ranolazin [Antianginal Therapy: Focus on Ranolazine]. Consilium medicum, 2013, № 5, pp. 26­30. (in Russian).Chaitman B.R., Pepine C.J., Parker J.O., Skopal J., Chumakova G., Kuch J., Wang W., Skettino S.L., W olff A.A. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trial. JAMA, 2004, vol. 291, № 3, рр. 309-316.Chaitman B.R., Pepine C.J., Parker J.O., Skopal J., Chumakova G., Kuch J., Wang W., Skettino S.L., W olff A.A. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trial. JAMA, 2004, vol. 291, № 3, рр. 309-316.

The authors declare that there are no conflicts of interest present.